纵横研报
Ticker Detail

600829.SHG

¥9.89+10.01% 人民同泰 Drug Manufacturers - Specialty & Generic
00Reports China 医疗健康
HPGC Renmintongtai Pharmaceutical Corp
医疗健康 · 专科与仿制药

HPGC Renmintongtai Pharmaceutical Corporation engages in the wholesale and retail of pharmaceutical products in China and internationally. The company offers chemical drugs, traditional Chinese medicine, biological products, and medical supplies; medical instruments, traditional Chinese medicine decoction pieces, health foods, daily necessities, glassware, and chemical reagents, etc.; It serves its products through e-commerce platforms, direct sales, and a chain of direct stores and online B2C, O2O, etc. The company was founded in 1950 and is headquartered in Harbin, China. HPGC Renmintongtai Pharmaceutical Corporation is a subsidiary of Harbin Pharmaceutical Group Co., Ltd.

MARKET 市值 4.73B CNY PE 34.0x Fwd 38.8x 52W ¥7.41 – ¥18.13 EODHD · Q 2026-03-31 · 同步 2026-07-12
QUALITY PEG 营收 YoY 5.9% ROE 4.6% 营业利润率 2.6% 净利润率 1.3%

暂无相关研报

数据库中已收录该标的的基本面数据,可发起一份定制研报。

CUSTOM RESEARCH · 定制研报 没找到完全契合的标的?让我们替你做一份。 告诉我们你关心的标的与偏好,1 个工作日内在站内上线。 开始定制